BSc CPA - KTRA Old CFO Sec

KTRADelisted Stock  USD 6.30  0.14  2.17%   

Insider

BSc CPA is CFO Sec of KTRA Old
Age 55
Phone858 350 4364
Webhttps://www.kintara.com

KTRA Old Management Efficiency

The company has return on total asset (ROA) of (1.0376) % which means that it has lost $1.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.7077) %, meaning that it created substantial loss on money invested by shareholders. KTRA Old's management efficiency ratios could be used to measure how well KTRA Old manages its routine affairs as well as how well it operates its assets and liabilities.
KTRA Old currently holds 2.44 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. KTRA Old has a current ratio of 3.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about KTRA Old's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christopher RoenfeldtForte Biosciences
N/A
Jeff YorkSeres Therapeutics
N/A
Edgar MDBolt Biotherapeutics
78
Joseph HazeltonDyadic International
49
David MBALisata Therapeutics
61
Jeffrey WelchGeoVax Labs
N/A
Frank TufaroTheriva Biologics
69
Eric PowersLisata Therapeutics
N/A
Shane LeaCellectar Biosciences
N/A
Antony CPAForte Biosciences
58
Andrew GuttadauroOncolytics Biotech
57
Jeff NelsonMilestone Pharmaceuticals
43
FCA FCAOncolytics Biotech
N/A
Steven RuhlForte Biosciences
68
Karen BergmanBolt Biotherapeutics
N/A
Grey WilkinsonOncolytics Biotech
N/A
FACC FAHAMilestone Pharmaceuticals
66
Mark NewmanGeoVax Labs
70
Bruce MDBolt Biotherapeutics
N/A
Steven CPATheriva Biologics
64
Vincent PerroneTheriva Biologics
N/A
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California. Kintara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. KTRA Old (KTRA) is traded on NASDAQ Exchange in USA and employs 1 people.

Management Performance

KTRA Old Leadership Team

Elected by the shareholders, the KTRA Old's board of directors comprises two types of representatives: KTRA Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KTRA. The board's role is to monitor KTRA Old's management team and ensure that shareholders' interests are well served. KTRA Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KTRA Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
BSc CPA, CFO Sec
BBA CPA, CEO Pres
BSc MA, CoFounder Officer
Greg Johnson, Acting Operations
CPA BBA, CEO and Presidentident

KTRA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is KTRA Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in KTRA Stock

If you are still planning to invest in KTRA Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KTRA Old's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated